According to the study authors, "The extent of the burden indicates that continued research to determine the cause of and potential therapies for CFS could provide substantial benefit both for individual patients and for the nation."
Dr William Reeves, from the Centers for Disease Control and Prevention, Atlanta, and his colleagues interviewed 56,000 people from Wichita, Kansas over the phone. Of these, 3,551 people reported that they had been suffering from fatigue for more than a month. 43 of these fatigued individuals were classified as suffering from CFS during a clinical evaluation, conducted as part of the study.
The lost productivity caused by CFS in Wichita was then estimated on the basis of information given by participants about their current employment status, household income, and occupation. Respondents also outlined the amount of housework they did and, for those with CFS, the amount that they had done prior to suffering from the condition.
Approximately a quarter of those with CFS, who would otherwise have been employed, left their jobs on account of their illness. Those who continued to work lost about one-third of their income.
The annual total value of lost productivity was estimated at about US$20,000 per person with CFS. This loss was the result of a 37% decline in household productivity and a 54% reduction in labour force productivity among people with the syndrome.
This value was then extrapolated to the whole of the USA, assuming that a similar proportion of the population was affected by CFS, around 450,000 individuals in total. This would give a total loss of US$9.1 billion, made up of US$2.3 billion from lost household productivity and US$6.8 billion from lost labour force productivity.
This could well be an underestimate of the total cost to the country because the Wichita study only picked up people currently suffering from CFS. Thus, those who were temporarily in remission or who had recovered from CFS would not have been taken into account. Such people are likely to be earning less than they would have if they had remained healthy throughout their working life. Their loss of work time would have caused them to lose work experience and, thus, reduce their promotion potential.
This press release is based on the following article:
The economic impact of Chronic Fatigue Syndrome
Kenneth J Reynolds, Suzanne D Vernon, Ellen Bouchery, William C Reeves
Cost Effectiveness and Resource Allocation 2004, 2:4
To be published Monday 21 June 2004
Upon publication this article will be available free of charge according to the journal's Open Access policy at: http://www.resource-allocation.com/content/2/1/4
Please quote the journal in any story you write, and link to the article if you are writing for the web.
For further information about this research please contact the Centers for Disease Control press office on +1 404.639.3286
Alternatively, or for more information about the journal or Open Access publishing, contact Gemma Bradley by email at email@example.com or by phone on: +44 (0)20 7631 9931
Cost Effectiveness and Resource Allocation (http://www.resource-allocation.com/home) is an Open Access, peer-reviewed online journal that considers articles on all aspects of cost-effectiveness analysis, including conceptual or methodological work, economic evaluations, and policy analysis related to resource allocation at a national or international level.
Cost Effectiveness and Resource Allocation is published by BioMed Central (http://www.biomedcentral.com), an independent online publishing house committed to providing Open Access to peer-reviewed biological and medical research. This commitment is based on the view that immediate free access to research and the ability to freely archive and reuse published information is essential to the rapid and efficient communication of science. BioMed Central currently publishes over 100 journals across biology and medicine. In addition to open-access original research, BioMed Central also publishes reviews, commentaries and other non-original-research content. Depending on the policies of the individual journal, this content may be open access or provided only to subscribers.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.